Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Braz. J. Pharm. Sci. (Online) ; 56: e17836, 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1132033

RESUMO

This study was carried out in order to compare the relative bioavailability of two different formulations containing 400 mg of acetaminophen + 4 mg of phenylephrine hydrochloride + 4 mg of chlorpheniramine maleate, Test formulation (Cimegripe®) and Reference formulation (Resfenol®) in 84 healthy volunteers of both sexes under fasting conditions. The study was conducted in a single dose, randomized, open-label, crossover 3-way and partially replicated. The tolerability was evaluated by the monitoring of adverse events and vital signs, results of clinical and laboratory tests. Plasma concentrations were quantified by validated bioanalytical methods using the ultra-performance liquid chromatography coupled to tandem mass spectrometry. The Cmax, Tmax, AUC0-t, AUC0-inf, T1/2 and Kel pharmacokinetic parameters were calculated from these obtained concentrations. The 90% confidence intervals were constructed for the ratio reference/test from the geometric average of the Cmax and AUC parameters which were comprised between 80% and 125%. Only the Cmax parameter of the phenylephrine was applied the scaled average bioequivalence due to the intraindividual coefficient of variation > 30% obtained, thus extending the acceptance limits of the interval. It can be concluded that the two formulations were bioequivalent in terms of rate and absorption extent and thus interchangeable


Assuntos
Humanos , Masculino , Feminino , Fenilefrina/análise , Cápsulas/classificação , Disponibilidade Biológica , Clorfeniramina/análise , Acetaminofen/análise , Espectrometria de Massas/métodos , Dose Única , Jejum/efeitos adversos , Estudos Cross-Over , Absorção/efeitos dos fármacos , Espectrometria de Massas em Tandem/métodos , Voluntários Saudáveis/classificação
2.
Braz. J. Pharm. Sci. (Online) ; 55: e18075, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1039056

RESUMO

The present study was designed to investigate the effect of early and late administration of phenylephrine during ischemia against regional ischemia-reperfusion injuries in an isolated rat heart model. All animals were randomly divided into experimental groups: (I) IR (Ischemic/ reperfusion): the hearts underwent 35 min of regional ischemia followed by 60 min of reperfusion; (II) 5HD-IR-0: the hearts were perfused for 5 min with 5HD (5-hydroxydecanoate, specific mKATP channel blocker, 100 µM) at the onset of regional ischemia; (III) 5HD-IR-20: the hearts were perfused for 5 min with 5HD 20 min after regional ischemia; (IV) PE-IR-10: the hearts were perfused for 5 min with phenylephrine 10 min after regional ischemia; (V) PE-IR-30: the hearts were perfused for 5 min with phenylephrine (100 µM) 30 min after regional ischemia; (VI) PE-5HD-IR-10 group: the hearts were perfused for 5 min with 5HD at the onset of regional ischemia after which phenylephrine was administrated as in group IV; and (VII) PE-5HD-IR-30: the hearts were perfused for 5 min with 5HD 20 min after the ischemia and then phenylephrine was administrated as in group V. The hemodynamic parameters were recorded throughout the experiment. Ischemia-induced arrhythmias, myocardial infarct size (IS), creatin kinase-MB isoenzyme (CK-MB), plasma lactate dehydrogenase (LDH) activities, and coronary blood flow (CBF) were measured in all animals. Perfusion of phenylephrine 30 min after the regional ischemia curtailed the myocardial infarct size, reduced CK-MB, and improved cardiac function and CBF. Administration of 5HD 30 min after the ischemia abolished cardioprotective effects of phenylephrine in the late phase. These results suggest the involvement of mKATP in the mechanism of phenylephrine-induced late preconditioning.


Assuntos
Animais , Masculino , Ratos , Fenilefrina/análise , Fenilefrina/efeitos adversos , Isquemia/tratamento farmacológico , Reperfusão
3.
Arq. bras. cardiol ; Arq. bras. cardiol;105(2): 160-167, Aug. 2015. tab, ilus
Artigo em Inglês | LILACS | ID: lil-758002

RESUMO

AbstractBackground:Hypertension is a public health problem and increases the incidence of cardiovascular diseases.Objective:To evaluate the effects of a resistance exercise session on the contractile and relaxing mechanisms of vascular smooth muscle in mesenteric arteries of NG-nitro L-arginine methyl ester (L-NAME)-induced hypertensive rats.Methods:Wistar rats were divided into three groups: control (C), hypertensive (H), and exercised hypertensive (EH). Hypertension was induced by administration of 20 mg/kg of L-NAME for 7 days prior to experimental protocols. The resistance exercise protocol consisted of 10 sets of 10 repetitions and intensity of 40% of one repetition maximum. The reactivity of vascular smooth muscle was evaluated by concentration‑response curves to phenylephrine (PHEN), potassium chloride (KCl) and sodium nitroprusside (SNP).Results:Rats treated with L-NAME showed an increase (p < 0.001) in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) compared to the initial period of induction. No difference in PHEN sensitivity was observed between groups H and EH. Acute resistance exercise reduced (p < 0.001) the contractile response induced by KCl at concentrations of 40 and 60 mM in group EH. Greater (p < 0.01) smooth muscle sensitivity to NPS was observed in group EH as compared to group H.Conclusion:One resistance exercise session reduces the contractile response induced by KCl in addition to increasing the sensitivity of smooth muscle to NO in mesenteric arteries of hypertensive rats.


ResumoFundamento:A hipertensão é um problema de saúde pública e faz aumentar a incidência das doenças cardiovasculares.Objetivo:Avaliar os efeitos de uma sessão de exercício resistido sobre os mecanismos contráteis e relaxantes do músculo liso vascular em artéria mesentérica de ratos hipertensos induzidos por L-NAME.Métodos:Ratos Wistar foram divididos em três grupos: Controle (C), Hipertenso (H) e Hipertenso Exercitado (HE). A hipertensão foi induzida pela administração de 20 mg/kg de NG-nitro L-arginina metil éster (L-NAME) durante sete dias antes dos protocolos experimentais. O protocolo de exercício resistido consistiu em dez séries de dez repetições e intensidade de 40% de uma repetição máxima. A reatividade do músculo liso vascular foi avaliada através de curvas concentração-resposta para a fenilefrina (FEN), cloreto de potássio (KCl) e nitroprussiato de sódio (NPS).Resultados:Os ratos tratados com L-NAME apresentaram aumento (p < 0,001) da Pressão Arterial Sistólica (PAS), da Pressão Arterial Diastólica (PAD) e da Pressão Arterial Média (PAM) quando comparados ao período inicial da indução. Não foi observada diferença na sensibilidade da FEN entre os grupos H e HE. O exercício resistido agudo reduziu (p < 0,001) a resposta contrátil induzida pelo KCl nas concentrações de 40 e 60 mM do grupo HE quando comparado ao grupo H. Foi observado maior (p < 0,01) sensibilidade do músculo liso ao NPS no grupo HE quando comparado ao grupo H.Conclusão:Uma sessão de exercício resistido reduz as respostas contráteis induzidas pelo KCl, além de aumentar a sensibilidade do músculo liso ao NO em artéria mesentérica de ratos hipertensos.


Assuntos
Animais , Tolerância ao Exercício/fisiologia , Hipertensão/fisiopatologia , Músculo Liso Vascular/fisiopatologia , Condicionamento Físico Animal/fisiologia , Peso Corporal , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Inibidores Enzimáticos/farmacologia , Artérias Mesentéricas/fisiopatologia , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Músculo Liso Vascular/efeitos dos fármacos , NG-Nitroarginina Metil Éster/farmacologia , Nitroprussiato/análise , Fenilefrina/análise , Cloreto de Potássio/análise , Ratos Wistar , Fatores de Tempo
4.
Arq Bras Cardiol ; 105(2): 160-7, 2015 Aug.
Artigo em Inglês, Português | MEDLINE | ID: mdl-26107814

RESUMO

BACKGROUND: Hypertension is a public health problem and increases the incidence of cardiovascular diseases. OBJECTIVE: To evaluate the effects of a resistance exercise session on the contractile and relaxing mechanisms of vascular smooth muscle in mesenteric arteries of NG-nitro L-arginine methyl ester (L-NAME)-induced hypertensive rats. METHODS: Wistar rats were divided into three groups: control (C), hypertensive (H), and exercised hypertensive (EH). Hypertension was induced by administration of 20 mg/kg of L-NAME for 7 days prior to experimental protocols. The resistance exercise protocol consisted of 10 sets of 10 repetitions and intensity of 40% of one repetition maximum. The reactivity of vascular smooth muscle was evaluated by concentration­response curves to phenylephrine (PHEN), potassium chloride (KCl) and sodium nitroprusside (SNP). RESULTS: Rats treated with L-NAME showed an increase (p < 0.001) in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) compared to the initial period of induction. No difference in PHEN sensitivity was observed between groups H and EH. Acute resistance exercise reduced (p < 0.001) the contractile response induced by KCl at concentrations of 40 and 60 mM in group EH. Greater (p < 0.01) smooth muscle sensitivity to NPS was observed in group EH as compared to group H. CONCLUSION: One resistance exercise session reduces the contractile response induced by KCl in addition to increasing the sensitivity of smooth muscle to NO in mesenteric arteries of hypertensive rats.


Assuntos
Tolerância ao Exercício/fisiologia , Hipertensão/fisiopatologia , Músculo Liso Vascular/fisiopatologia , Condicionamento Físico Animal/fisiologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Pressão Sanguínea/fisiologia , Peso Corporal , Inibidores Enzimáticos/farmacologia , Artérias Mesentéricas/fisiopatologia , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Músculo Liso Vascular/efeitos dos fármacos , NG-Nitroarginina Metil Éster/farmacologia , Nitroprussiato/análise , Fenilefrina/análise , Cloreto de Potássio/análise , Ratos Wistar , Fatores de Tempo
5.
Anal Bioanal Chem ; 407(19): 5649-59, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26025549

RESUMO

The use of the successive projections algorithm (SPA) for elimination of uninformative variables in interval selection, and unfold partial least squares regression (U-PLS) modeling of excitation-emission matrices (EEM), when under the inner filter effect (IFE) is reported for first time. Post-calibration residual bilinearization (RBL) was employed against events of unknown components in the test samples. The inner filter effect can originate changes in both the shape and intensity of analyte spectra, leading to trilinearity losses in both modes, and thus invalidating most multiway calibration methods. The algorithm presented in this paper was named iSPA-U-PLS/RBL. Both simulated and experimental data sets were used to compare the prediction capability during: (1) simulated EEM; and (2) quantitation of phenylephrine (PHE) in the presence of paracetamol (PAR) (or acetaminophen) in water samples. Test sets containing unexpected components were built in both systems [a single interference was taken into account in the simulated data set, while water samples were added with varying amounts of ibuprofen (IBU), and acetyl salicylic acid (ASA)]. The prediction results and figures of merit obtained with the new algorithm were compared with those obtained with U-PLS/RBL (without intervals selection), and with the well-known parallel factors analysis (PARAFAC). In all cases, U-PLS/RBL displayed better EEM handling capability in the presence of the inner filter effect compared with PARAFAC. In addition, iSPA-U-PLS/RBL improved the results obtained with the full U-PLS/RBL model, in this case demonstrating the potential of variable selection.


Assuntos
Algoritmos , Modelos Químicos , Acetaminofen/análise , Aspirina/análise , Fluorescência , Ibuprofeno/análise , Análise dos Mínimos Quadrados , Fenilefrina/análise
6.
Talanta ; 109: 107-15, 2013 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-23618146

RESUMO

A methodology based on second-order data (excitation emission matrices) modeling with one of most popular algorithms presenting the second-order advantage, parallel factor analysis (PARAFAC), combined with transference of calibration is proposed to predict the analyte concentration when significant inner filter effects occur, even in the presence of unexpected sample components. The quantitation of phenylephrine hydrochloride (PHE) in water samples (concentrations ranged between 250 and 750 ng mL(-1)) in the presence of ibuprofen, acetyl salicylic acid and paracetamol (which produce inner filter effect across the useful wavelength range) was achieved. The strategy allows reducing the experimental work and increasing the analytical sensitivity in the determination of the analyte of interest in the presence of unexpected compounds and matrix effect caused by inner filter, avoiding the preparation of a large number of solutions and maintaining acceptable figures of merit. Recoveries between 97 and 102% for validation and real spiked water samples, respectively, and a relative prediction error of 5% were achieved. Results were compared with those obtained after the application of the classical standard addition method combined with PARAFAC, carrying out five additions to each sample, in triplicate. The presented methodology constitutes a simple and low-cost method for the determination of PHE in water samples with a considerable reduction in standard handling and time. This methodology can be extended to other systems presenting matrix effect and, consequently, can become in a useful tool to know the amount of pharmaceuticals in the aquatic environment and to evaluate the effect of conventional wastewater treatment plants in the elimination of pharmaceutical compounds.


Assuntos
Modelos Químicos , Preparações Farmacêuticas/análise , Fenilefrina/análise , Espectrometria de Fluorescência , Poluentes Químicos da Água/análise , Acetaminofen/análise , Algoritmos , Aspirina/análise , Calibragem , Ibuprofeno/análise , Limite de Detecção , Padrões de Referência , Espectrometria de Fluorescência/instrumentação , Espectrometria de Fluorescência/métodos , Espectrometria de Fluorescência/normas , Águas Residuárias/química
7.
J Pharm Biomed Anal ; 31(1): 39-46, 2003 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-12560047

RESUMO

A capillary zone electrophoresis (CZE) method has been developed to separate and quantitate naphazoline (NAPH), dyphenhydramine (DIP) and phenylephrine (PHE) in nasal solutions. Samples were diluted 1:25 in ultrapure water and injected at the anodic end. A central composite design has been used to optimise the experimental conditions for a complete and fast separation of the active ingredients studied. Critical parameters such as voltage, pH and buffer concentration have been studied to evaluate how they affect responses such as resolution and migration times. Separation was performed on a silica capillary with 75 microm I.D. and 70 cm total length at an applied voltage of 17.7 kV with a phosphate run buffer of pH 3.72 and 0.063 mol l(-1). Calibration curves were prepared for NAPH, DIP and PHE. For each analyte, the correlation coefficients were >0.999 (n=15). The RSD% of six replicate injections for each analyte were reasonably good. The method was applied to the quantitation of the three components in a commercial dosage form. The proposed method has the advantage of needing a very simple sample pretreatment and being faster than a typical HPLC chromatographic method.


Assuntos
Difenidramina/análise , Nafazolina/análise , Fenilefrina/análise , Administração Intranasal , Algoritmos , Eletroforese Capilar , Excipientes , Concentração de Íons de Hidrogênio , Indicadores e Reagentes , Soluções Farmacêuticas , Reprodutibilidade dos Testes , Espectrofotometria Ultravioleta
8.
J Pharm Biomed Anal ; 30(3): 791-9, 2002 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-12367705

RESUMO

The separation of basic nitrogenous compounds commonly used as active ingredients in cold medicine formulations by micellar electrokinetic capillary chromatography and capillary zone electrophoresis with direct absorptiometric detection was investigated. The type and composition of the background electrolyte (BGE) were investigated with respect to separation selectivity and BGE stability. BGE of 10 mM sodium dihydrogenphosphate-sodium tetraborate buffer containing 10 mM SDS and 10% acetonitrile, pH 9.0 was found to be optimal. Dextromethorphan hydrobhromide, diphenhydramine hydrochloride and phenylephrine hydrochloride were baseline-separated in less than 11 min, giving separation efficiencies of up to 494,000 theoretical plates, reproducibility of corrected peaks areas below 3% relative standard deviation and concentration detection limits from 2.5 to 5.5 microg ml(-1). Detection was performed at 196 and 214 nm.


Assuntos
Dextrometorfano/análise , Difenidramina/análise , Expectorantes/análise , Descongestionantes Nasais/análise , Fenilefrina/análise , Química Farmacêutica , Dextrometorfano/química , Difenidramina/química , Eletroforese Capilar/métodos , Expectorantes/química , Descongestionantes Nasais/química , Fenilefrina/química
9.
J AOAC Int ; 85(4): 875-8, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12180681

RESUMO

This paper presents a method for the determination of phenylephrine hydrochloride in pharmaceuticals by spectrophotometric flow injection analysis exploiting the reaction with potassium ferricyanide and 4-aminoantipyrine, which leads to the formation of a condensation product with strong absorptivity at 500 nm. The linear dynamic range was between 0.95 and 9 mg/L, with a limit of detection of 0.2 mg/L and a sampling throughput of 120 samples per hour. The method was applied to eyewashes and nasal decongestant liquid medicines.


Assuntos
Análise de Injeção de Fluxo/métodos , Fenilefrina/análogos & derivados , Fenilefrina/análise , Espectrofotometria/métodos , Ampirona , Colorimetria , Ferricianetos , Descongestionantes Nasais/análise , Soluções Oftálmicas/análise , Soluções Farmacêuticas/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA